These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38395299)

  • 1. Validation of the SCORE2 risk prediction algorithm in a Portuguese population: A new model to estimate 10-year cardiovascular disease incidence in Europe.
    Temtem M; Mendonça MI; Santos M; Sá D; Sousa F; Freitas S; Borges S; Henriques E; Rodrigues M; Soares C; Rodrigues R; Serrão M; Drumond A; Sousa AC; Palma Reis R
    Rev Port Cardiol; 2024 Aug; 43(8):437-444. PubMed ID: 38395299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive improvement of adding coronary calcium score and a genetic risk score to a traditional risk model for cardiovascular event prediction.
    Temtem M; Mendonça MI; Gomes Serrão M; Santos M; Sá D; Sousa F; Soares C; Rodrigues R; Henriques E; Freitas S; Borges S; Rodrigues M; Guerra G; Drumond Freitas A; Sousa AC; Palma Dos Reis R
    Eur J Prev Cardiol; 2024 Apr; 31(6):709-715. PubMed ID: 38175668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk assessment using SCORE2 in a population with hypertension - The reality at a primary health care unit.
    Pereira Santos S; Guedes S; Pesqueira R; Stuart J; Carvalho AM; Correia P; Lourenço Ribeiro I; Teixeira ÂM
    Rev Port Cardiol; 2024 Nov; 43(11):601-610. PubMed ID: 39004141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort.
    van Trier TJ; Snaterse M; Boekholdt SM; Scholte Op Reimer WJM; Hageman SHJ; Visseren FLJ; Dorresteijn JAN; Peters RJG; Jørstad HT
    Eur J Prev Cardiol; 2024 Jan; 31(2):182-189. PubMed ID: 37793098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk assessment in Portugal's primary health care system: SCORE vs. SCORE2.
    Silva C; Mendes JE; Ramos R; Gaspar A; Leal F; Mendes N
    Rev Port Cardiol; 2024 Aug; 43(8):449-455. PubMed ID: 38395300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.
    SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration
    Eur Heart J; 2023 Jul; 44(28):2544-2556. PubMed ID: 37247330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of SCORE2 and SCORE2-OP risk algorithms in a Cypriot cohort.
    Nicolaides AN; Griffin M; Panayiotou AG; Tyllis T; Bond D; Georgiou N; Kyriacou E; Avraamides C; Martin RM
    Int Angiol; 2022 Dec; 41(6):492-499. PubMed ID: 36285529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.
    SCORE2 working group and ESC Cardiovascular risk collaboration
    Eur Heart J; 2021 Jul; 42(25):2439-2454. PubMed ID: 34120177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2.
    Hageman SHJ; Petitjaen C; Pennells L; Kaptoge S; Pajouheshnia R; Tillmann T; Blaha MJ; McClelland RL; Matsushita K; Nambi V; Klungel OH; Souverein PC; van der Schouw YT; Verschuren WMM; Lehmann N; Erbel R; Jöckel KH; Di Angelantonio E; Visseren FLJ; Dorresteijn JAN
    Eur J Prev Cardiol; 2023 Oct; 30(15):1705-1714. PubMed ID: 37264679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the general Framingham Risk Score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population.
    Kasim SS; Ibrahim N; Malek S; Ibrahim KS; Aziz MF; Song C; Chia YC; Ramli AS; Negishi K; Mat Nasir N
    Lancet Reg Health West Pac; 2023 Jun; 35():100742. PubMed ID: 37424687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort.
    Santos-Ferreira C; Baptista R; Oliveira-Santos M; Moura JP; Gonçalves L
    BMC Cardiovasc Disord; 2020 Jun; 20(1):301. PubMed ID: 32560700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis.
    Ferraz-Amaro I; Corrales A; Atienza-Mateo B; Vegas-Revenga N; Prieto-Peña D; Sánchez-Martín J; Almeida C; Quevedo-Abeledo JC; Blanco R; González-Gay MÁ
    Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up.
    Polo Y la Borda J; Castañeda S; Sánchez-Alonso F; Plaza Z; García-Gómez C; Ferraz-Amaro I; Erausquin C; Valls-García R; Fábregas MD; Delgado-Frías E; Mas AJ; González-Juanatey C; Llorca J; González-Gay MA;
    Semin Arthritis Rheum; 2024 Jun; 66():152442. PubMed ID: 38555727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines.
    Mortensen MB; Tybjærg-Hansen A; Nordestgaard BG
    JAMA Cardiol; 2022 Aug; 7(8):836-843. PubMed ID: 35793078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
    SCORE2-OP working group and ESC Cardiovascular risk collaboration
    Eur Heart J; 2021 Jul; 42(25):2455-2467. PubMed ID: 34120185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Way to "SCORE" Risk: Updates on the ESC Scoring System and Incorporation into ESC Cardiovascular Prevention Guidelines.
    Graham IM; Di Angelantonio E; Huculeci R;
    Curr Cardiol Rep; 2022 Nov; 24(11):1679-1684. PubMed ID: 36441402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Risk Scores and Migraine Status.
    Al-Hassany L; MaassenVanDenBrink A; Kurth T
    JAMA Netw Open; 2024 Oct; 7(10):e2440577. PubMed ID: 39436645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone proteins are associated with cardiovascular risk according to the SCORE2-Diabetes algorithm.
    González-Salvatierra S; García-Martín A; García-Fontana B; Martínez-Heredia L; García-Fontana C; Muñoz-Torres M
    Cardiovasc Diabetol; 2024 Aug; 23(1):311. PubMed ID: 39182106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding ethnicity to cardiovascular risk prediction: External validation and model updating of SCORE2 using data from the HELIUS population cohort.
    van Apeldoorn JAN; Hageman SHJ; Harskamp RE; Agyemang C; van den Born BH; van Dalen JW; Galenkamp H; Hoevenaar-Blom MP; Richard E; van Valkengoed IGM; Visseren FLJ; Dorresteijn JAN; Moll van Charante EP
    Int J Cardiol; 2024 Dec; 417():132525. PubMed ID: 39244095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.
    de La Harpe R; Thorball CW; Redin C; Fournier S; Müller O; Strambo D; Michel P; Vollenweider P; Marques-Vidal P; Fellay J; Vaucher J
    Eur J Prev Cardiol; 2023 May; 30(7):561-571. PubMed ID: 36652418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.